Sens. Capito, Shaheen Lead Bipartisan IMPACT Act to Reform Opioid Use Disorder Medication Holding Period for Providers
November 25, 2021
November 25, 2021
CHARLESTON, West Virginia, Nov. 25 -- Sen. Shelley Moore Capito, R-West Virginia, issued the following news release:
U.S. Senators Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen (D-N.H.) this week introduced bipartisan legislation that would increase the amount of time a physician can hold long-acting injectable (LAI) buprenorphine - a form of medication for opioid use disorders - from a specialty pharmacy.
The current 14-day window is a barrier to health care provid . . .
U.S. Senators Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen (D-N.H.) this week introduced bipartisan legislation that would increase the amount of time a physician can hold long-acting injectable (LAI) buprenorphine - a form of medication for opioid use disorders - from a specialty pharmacy.
The current 14-day window is a barrier to health care provid . . .